41 research outputs found
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Full text link
Vollständige Remission fortgeschrittener autologer intrakranieller Gliome nach Therapie mit dem onkolytischen Parvovirus H-1
No full textMultiple intravenous injections of oncolytic Parvovirus H-1 lead to complete tumor regression of rat and human glioma xenografts similar to intratumoral therapy
No full textAn LC-MS/MS based candidate reference method for the quantification of androstenedione in human serum and plasma
No full textET-21 * COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER
No full text
